ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

SNG Synairgen Plc

6.50
0.00 (0.00%)
Last Updated: 12:03:48
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Synairgen Plc LSE:SNG London Ordinary Share GB00B0381Z20 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 6.50 6.00 6.48 - 121,343 12:03:48
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 0 -17.65M -0.0876 -0.74 13.09M
Synairgen Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker SNG. The last closing price for Synairgen was 6.50p. Over the last year, Synairgen shares have traded in a share price range of 4.20p to 10.62p.

Synairgen currently has 201,345,000 shares in issue. The market capitalisation of Synairgen is £13.09 million. Synairgen has a price to earnings ratio (PE ratio) of -0.74.

Synairgen Share Discussion Threads

Showing 276 to 299 of 98850 messages
Chat Pages: Latest  18  17  16  15  14  13  12  11  10  9  8  7  Older
DateSubjectAuthorDiscuss
22/3/2020
18:16
21 Mar '20 - 17:06 - 382 of 383 Edit
0 0 0


likya for you

dave44

hazl
22/3/2020
18:08
44.2% or 49m shares in public hands!22m were traded Thursday and Friday so if half were buys that reduces the available shares to 38m!Presumably a good number will want to keep them for the medium term so that means we are likely to get a really big upward squeeze on the SP!
dave444
22/3/2020
18:06
Markets don't close!
dave444
22/3/2020
18:02
Hazl, then you'd better get as many SNG as you can before it shuts! Haha

Just to let you know the markets are run electronically, by computers so will not shut.
This isn't xmas day, it's a pandemic!

likya123
22/3/2020
17:59
I think people will have to careful generally,in the stock market, at the moment.
There had been even the request, of closing markets, at one point.
Be careful out there folks!

IMO

hazl
22/3/2020
17:57
Sorry I hadn't read previous posts and got that from LSE.
That was why I asked the question rather than stating as a fact.
I see that had already been brought up here.

hazl
22/3/2020
17:51
Thank you toffeeman it was the first I had heard of it.
hazl
22/3/2020
17:41
Some people seriously need to take a chill pill...the past week this thread has been derailed by a lot of drivel and personal agendas which is burying useful and relevant posts.
adman50
22/3/2020
17:36
From the 18th March RNS

Wow!! In black and white...we've been approached and are in discussions!
This is very fast moving indeed!

"Since the outbreak of COVID-19, Synairgen has been approached by, and is in discussion with, a number of other medical, scientific, and Governmental bodies (both in the UK, US and internationally) seeking to investigate novel therapeutics in this area"

likya123
22/3/2020
15:52
No it's not!

AZN and SNG entered into a conditional licensing agreement which came to nothing.

toffeeman
22/3/2020
15:50
Is it true that AZ wanted to take Synairgen for £230 million about 3 years ago.?
I read on a different board.

hazl
22/3/2020
15:46
So obviously what everybody is looking for is potential treatments which could either reduce the severity of the disease or, ideally, to cure it all together.

“So a number of different sorts of approaches have been suggested.”

University of Southampton researchers are trialling the inhaled drug.

The trial will involve 100 patients at Southampton and up to 10 other NHS hospitals.

Participants will receive the current Covid-19 care, while inhaling either a placebo or SNG001 - a special formulation of the naturally occurring antiviral protein interferon beta 1a (IFN-beta), for 14 days.

The trial will be undertaken with Synairgen, a drug development company founded by University of Southampton professors.

hazl
22/3/2020
15:44
'Researchers in Southampton are conducting the trial and Nottingham University Hospitals have confirmed that they have joined and local patients can be included in it. '

link above thanks to warrenbe

hazl
22/3/2020
15:41
There is a consistent message,whenever a share has gone up a lot,by the envious.
That's all it is,usually.

hazl
22/3/2020
15:36
Nobbygnome - Ammu is a troll. He was asking same question on NYCT board. Best to ignore him or ban him. He is very disruptive. The question he asked is very embarrassing for someone who is on a share discussion board.
sellsell
22/3/2020
15:33
Why on earth is everybody talking of placing?!


We ought to be sitting back smugly,delighted at the recent news!

This went up over 50% for a reason on Friday and its the best hope we have to fight back on this wretched virus!

Better than tests, better than advice, better than anything I've heard of so far!

Wheres the info again!

hazl
22/3/2020
15:28
>> ammu

Someone else hovering on the brink as I presume you are deliberately asking leading questions. Go and look at the results if you want to know the answer.

nobbygnome
22/3/2020
15:25
How much money did they made last year ?
ammu12
22/3/2020
15:19
Well if it was tomorrow morning I would guess 48-50p after the strong rise late on Friday. It will not be at a big discount that’s for sure. And it may never happen if they sign some sort of marketing deal.
nobbygnome
22/3/2020
15:18
Be Draconian Nobby!
toffeeman
22/3/2020
15:16
What price would they do a placing at ?
ammu12
22/3/2020
15:00
Jeez! No they weren’t going to take them over; it was just a licensing deal with certain financial terms....
nobbygnome
22/3/2020
14:57
Ok Nobby, so there was a deal to takover Synairgen by Astra Zeneca for $232 million 3 years ago if certain milestones were met over the course of a number of years...is that still the case?

And what price if covid-19 trials are a success?

likya123
22/3/2020
14:55
Someone on here today cited the previous AZN deal and the INEXAS study that was terminated by AZN with the rights to AZD9412 returned to Synairgen. The reason for the termination was that the drugs affect on severe exacerbations could not be determined. In particular they mention cold infections not affecting trial patients asthma. I am assuming that AZD9412 is the same as SNG001 but does anyone know if the company followed up on this and whether they undertook any other study to evaluate this exacerbation. Just curious.
davew28
Chat Pages: Latest  18  17  16  15  14  13  12  11  10  9  8  7  Older

Your Recent History

Delayed Upgrade Clock